CombesR.D. & BallsM. (2015). A critical assessment of the scientific basis, and implementation, of regulations for the safety assessment and marketing of innovative tobacco-related products. ATLA43, 251–290.
4.
DollR. & HillA.B. (1950). Smoking and carcinoma of the lung. Preliminary Report. BMJ2, 739–748. [Also available at: Bulletin of the World Health Organisation 7784–93 (1999).]
5.
DollR., PetoR., BorehamJ. & SutherlandI. (2004). Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ328, 1519–1528.
6.
TanC.E. & GlantzS.A. (2012). Association between smoke-free legislation and hospitalizations for cardiac, cerebrovascular, and respiratory diseases: A meta-analysis. Circulation126, 2177–2183.
7.
BenowitzN.L. (2009). Pharmacology of nicotine: Addiction, smoking-induced disease, and therapeutics. Annual Review of Pharmacology & Toxicology49, 57–71.
8.
TalhoutR., SchulzT., FlorekE., van BenthemJ., WesterP. & OpperhuizenA. (2011). Hazardous compounds in tobacco smoke. International Journal of Environmental Research & Public Health8, 613–628.
